The course of subjective and objective chemosensory dysfunction in hospitalized patients with COVID-19: a 6-month follow-up.

Mattis BertlichClemens StihlEnzo LüsebrinkJohannes C HellmuthClemens SchererSaskia FreytagJennifer Lee SpiegelIvelina StoychevaMartin CanisBernhard G WeissFriedrich IhlerFrank Haubner

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021)

SARS-CoV-2 patients with subjectively impaired chemosensory function regularly perform poorly in objective measurements. About 70% of patients suffering from olfactory dysfunction in SARS-CoV-2 quickly recover-the rest still suffers from considerable impairment 6 months after infection.

Keyphrases

sars cov
end stage renal disease
respiratory syndrome coronavirus
oxidative stress
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
patient reported outcomes
sleep quality
coronavirus disease
depressive symptoms